Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P D Zenobi"'
Publikováno v:
Thrombosis and Haemostasis. 70:1009-1013
SummaryIn vitro studies have shown that insulin and IGF-1 releases the fibrinolytic inhibitor plasminogen activator inhibitor-1 (PAI-1) from cells of hepatic origin. To investigate the effects of IGF-1 on fibrinolysis: 1) cultured hepatoma cells were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af625d615573dc5ac54c7bdbf5ad524c
https://doi.org/10.1055/s-0038-1649716
https://doi.org/10.1055/s-0038-1649716
Publikováno v:
Journal of Clinical Investigation. 90:2234-2241
Hyperglycemia, hyperinsulinemia, and insulin resistance cause vascular disease in type 2 diabetes mellitus. Dietary treatment alone often fails and oral drugs or insulin enhance hyperinsulinemia. In previous studies, an intravenous bolus of recombina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4336c63b86517d60f4c9ad6ded37317b
https://doi.org/10.1172/jci116109
https://doi.org/10.1172/jci116109
Publikováno v:
Journal of Clinical Investigation. 89:1908-1913
Insulin-like growth factor-I (IGF-I) and insulin interact with related receptors to lower plasma glucose and to exert mitogenic effects. Recombinant human IGF-I (rhIGF-I) was recently shown to decrease serum levels of insulin and C-peptide in fasted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8229a5079b4dc43f36ce0132821a17c5
https://doi.org/10.1172/jci115796
https://doi.org/10.1172/jci115796
Autor:
Walter F. Riesen, Keller A, Ernst Rudolf Prof Dr Froesch, Glatz Y, P D Zenobi, Jaeggi-Groisman Se, Graf S, Schoenle Ej
Publikováno v:
European journal of endocrinology. 131(3)
Zenobi PD, Glatz Y, Keller A, Graf S, Jaeggi-Groisman SE, Riesen WF, Schoenle EJ, Froesch ER. Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A. Eur J Endocrinol 1994;131:251–7. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05983ac22e44cc2964be882567ba2616
https://pubmed.ncbi.nlm.nih.gov/7921209
https://pubmed.ncbi.nlm.nih.gov/7921209
Publikováno v:
Thrombosis and haemostasis. 70(6)
In vitro studies have shown that insulin and IGF-1 releases the fibrinolytic inhibitor plasminogen activator inhibitor-1 (PAI-1) from cells of hepatic origin. To investigate the effects of IGF-1 on fibrinolysis: 1) cultured hepatoma cells were grown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6b0195be8be3eab13e2a81664608dec
https://pubmed.ncbi.nlm.nih.gov/8165592
https://pubmed.ncbi.nlm.nih.gov/8165592
Publikováno v:
Diabetologia. 36(5)
Type 2 (non-insulin-dependent) diabetes mellitus is associated with increased glucose, insulin, total and VLDL-triglyceride, and often total and LDL-cholesterol levels which promote vascular disease. Recombinant human insulin-like growth factor-I whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd3675533e096d2711b6a2e993053ff
https://pubmed.ncbi.nlm.nih.gov/8063048
https://pubmed.ncbi.nlm.nih.gov/8063048
Autor:
P D, Zenobi
Publikováno v:
Schweizerische medizinische Wochenschrift. 121(14)
Insulin (I) preparations used formerly contained a large number of protein contaminants which are thought to be immunogenic and, hence, caused lipodystrophy, I-allergy and sometimes antibody-mediated I-resistance in many patients. Monocomponent (MC)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1793b1a79020d04cc326d084c2bb5d47
https://pubmed.ncbi.nlm.nih.gov/2035004
https://pubmed.ncbi.nlm.nih.gov/2035004